The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancerPaulina Haight, Laura Chambers, Larry J. Copeland et al.|Gynecologic Oncology|2023Cited by 6
RETRACTED: Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancerCourtney Riedinger, Laura Chambers, David A. Mix Barrington et al.|Gynecologic Oncology|2024Cited by 2
Retraction notice to “Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer” [Gynecologic Oncology 183 (2024) 78–84]Courtney Riedinger, Laura Chambers, Larry J. Copeland et al.|Gynecologic Oncology|2024Cited by 1